Results 31 to 40 of about 86,749,145 (256)

Drug-related problems and dosage adjustment in patients with liver disease [PDF]

, 2012
The liver is essential for the metabolism of medicinal substances. Liver disease, especially liver cirrhosis, may lead to various pharmacokinetic and pharmacodynamic changes, predisposing patients with liver cirrhosis to adverse drug events (ADEs).
Franz, Carmen Carina
core   +1 more source

In Vitro Evaluation of Pro- and Anticoagulant Drugs in Children with End-Stage Liver Disease Undergoing Liver Transplantation [PDF]

, 2020
Background âPro- A nd anticoagulant drugs are commonly used in pediatric liver transplantation to prevent and treat thrombotic and bleeding complications.
Werner, Maureen J M, de Kleine, Ruben H J; id_orcid, Scheenstra, René, Bontemps, Sander T H, Hulscher, Jan B F, de Meijer, Vincent E, Porte, Robert J, Reyntjens, Koen M E M, Adelmeijer, Jelle, Lisman, Ton; id_orcid, Lisman, Ton, de Meijer, Vincent E; id_orcid, de Kleine, Ruben H J   +12 more
core   +2 more sources

Prevalence of Sarcopenia in Liver Cirrhosis Patients and Determinants of Survival in Cirrhotic Population: A Prospective Cohort Study [PDF]

Journal of Clinical and Diagnostic Research
Introduction: Chronic liver diseases are the leading cause of mortality and are associated with a significant reduction in health-related quality of life, as well as being a major complication in cirrhosis.
Bini Balakrishnan, B Vijayalakshmi, KT Shenoy, KB Leena, P Jayakumar, JK Mukkadan   +5 more
doaj   +1 more source

Evaluation of the correlation between six scoring systems for assessing the severity of end-stage liver disease and intraoperative blood loss during liver transplantation: a retrospective study

Clinical Transplantation and Research
Background : Patients with end-stage liver disease (ESLD) are particularly susceptible to intraoperative hemorrhage during liver transplantation (LT), a risk partly attributable to coagulopathy.
Amer Majeed, Noon E Abdelgadir, Momina Amer, Muhammad Shabbir, Mohammed Ibrahim, Mohamad S Nagy, Bilal Tufail, Luluah Altukhaifi, Areej A G AlFattani   +8 more
doaj   +1 more source

Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. [PDF]

, 2011
This review summarizes the document elaborated by the Italian Association for the Study of the Liver (AISF) ad hoc committee "Vascular disorders of the liver" on the primary circulatory liver diseases, which include Budd-Chiari syndrome, obstruction of ...
Riggio O, Sacerdoti D, Senzolo M, Primignani M, Italian Association for the Study of the Liver AISF ad hoc committee Vascular disorders of the liver, SACERDOTI, DAVID   +5 more
core   +1 more source

Hyponatremia in Cirrhosis: Comparative Evaluation of MELD and MELD-Na Scores for Predicting Short- and Long-Term Mortality

APIK Journal of Internal Medicine
Background: Hyponatremia is a frequent complication in patients with liver cirrhosis and is associated with increased morbidity and mortality. The model for end-stage liver disease (MELD) score is commonly used to predict prognosis in cirrhosis, but does
Goutami V. Kohir, Nagaraj Kotli
doaj   +1 more source

Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation

Chinese Medical Journal, 2018
Background: Contribution of model for end-stage liver disease incorporating with serum sodium (MELD-Na) score in predicting acute kidney injury (AKI) after orthotopic liver transplantation (OLT) is yet to be identified. This study assessed the prognostic
Yuan Cheng, Guo-Qing Wei, Qiu-Cheng Cai, Yi Jiang, Ai-Ping Wu   +4 more
doaj   +1 more source

Role of nutrition in liver transplantation for end-stage chronic liver disease [PDF]

, 2008
Patients with end-stage liver disease often reveal significant protein-energy malnutrition, which may deteriorate after listing for transplantation. Since malnutrition affects post-transplant survival, precise assessment must be an integral part of pre ...
Candinas, Daniel, Inderbitzin, Daniel, Stickel, Felix   +2 more
core   +2 more sources

Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation

Annals of Hepatology, 2012
Background. Living donor liver transplantation (LDLT) for patients with high model for end-stage liver disease (MELD) scores is controversial due to its poor outcome. However, there is little information regarding which factor would negatively impact the
Chuan Li, M.D., Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jia-Ying Yang, Ming-Qing Xu, Wen-Tao Wang, Yong-Gang Wei   +7 more
doaj   +1 more source

Keeping high model for end‐stage liver disease score liver transplantation candidates alive

, 2015
As the mean Model for End-Stage Liver Disease (MELD) score at time of liver transplantation continues to increase, it is crucial to implement preemptive strategies to reduce wait-list mortality.
Josh Levitsky, O'Leary, Jacqueline G, Levitsky, Josh, David P. Foley, Orloff, Susan L, Susan L. Orloff, Martin, Paul, Paul Martin, Foley, David P, Jacqueline G. O'Leary   +9 more
core   +1 more source